Hypoplastic Anemia and Myeloblastic Leukemia Following Chloramphenicol Therapy
- 9 November 1967
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 277 (19) , 1003-1005
- https://doi.org/10.1056/nejm196711092771904
Abstract
A PATHOGENIC relation between aplastic anemia and myeloblastic leukemia has long been suspected. It is well known that certain agents capable of producing aplastic anemia in man can also induce leukemia. Prime examples are benzene1 , 2 and irradiation.3 , 4 In addition, cases of leukemia developing during the course of hereditary hypoplastic syndromes have been recorded.5 , 6 The broad-spectrum antibiotic chloramphenicol7 8 9 has become the most commonly cited cause of acquired aplastic anemia. To date, only 1 case report of acute myeloblastic leukemia following aplasia secondary to chloramphenicol administration has been published.10 The purpose of this communication is to present 2 additional cases of chloramphenicol-induced . . .This publication has 19 references indexed in Scilit:
- The Aplastic Anaemia–Paroxysmal Nocturnal Haemoglobinuria SyndromeBritish Journal of Haematology, 1967
- Atypical LeukemiaJAMA, 1966
- Course and Prognosis in Aplastic AnaemiaBMJ, 1965
- INHIBITION OF PROTEIN SYNTHESIS IN MAMMALIAN CELL-FREE SYSTEMS BY CHLORAMPHENICOLThe Journal of Experimental Medicine, 1964
- Benzene Exposure and Aplastic Anemia Followed by Leukemia 15 Years LaterJAMA, 1963
- Cytogenetic Studies in Acute LeukaemiaBMJ, 1961
- Phenylbutazone and LeukaemiaBMJ, 1960
- Radiation LeukemogenesisThe American Journal of Medicine, 1960
- Acute Myeloblastic Leukaemia following Chloramphenicol TreatmentBMJ, 1957
- PRELEUKEMIC ACUTE HUMAN LEUKEMIAPublished by American Medical Association (AMA) ,1953